Acquiring Company
Pasithea Therapeutics Corp.
Acquired Company
Pasithea Therapeutics Corp.
Miami BeachMiami BeachBiotechnologyHealthcareHealth CareBiotechnologyHealthcareHealth CareDescription
Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous system (CNS) disorders, today announced that it acquired AlloMek Therapeutics, LLC (“AlloMek”), a privately-held biotechnology company. AlloMek’s lead therapeutic candidate, CIP-137401, is a potential best-in-class macrocyclic mitogen-activated protein kinase kinase 1/2 (MEK) inhibitor for use in a range of CNS-related indications, including neurofibromatosis type 1 (NF1) and Noonan syndrome, as well as potential synergy with our existing multiple sclerosis (MS) development program. The closing of the acquisition occurred on October 11, 2022.
Quick answer
Pasithea Therapeutics Corp. is acquiring Pasithea Therapeutics Corp., announced October 12, 2022. Pasithea Therapeutics Corp. is based in Miami Beach, Florida, United States.
- Who acquired Pasithea Therapeutics Corp?
- Pasithea Therapeutics Corp. agreed to acquire Pasithea Therapeutics Corp. on October 12, 2022.
- How much did Pasithea Therapeutics Corp. pay for Pasithea Therapeutics Corp?
- The deal value was not disclosed.
- Where are Pasithea Therapeutics Corp. and Pasithea Therapeutics Corp. based?
- Pasithea Therapeutics Corp. is based in Miami Beach, Florida, United States. Pasithea Therapeutics Corp. is based in Miami Beach, Florida, United States.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Healthcare
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Merck To Acquire Imago Biosciences, Inc. (November 21, 2022)
- Solid Biosciences Announces Acquisition Of Aavantibio And Concurrent $75 Million Private Placement, $75M (September 30, 2022)
- Novo Holdings Acquires Kabafusion (November 2, 2022)
- Atossa Therapeutics, Inc. To Acquire Stake In Privately Held Dynamic Cell Therapies As Part Of Overall Car-T Strategy (November 1, 2022)
- Geistlich Pharma North America, Inc. Acquires Lynch Biologics, Llc, A Biologics And Tissue Engineering Company (October 27, 2022)
- Symeres Acquires Exemplify Biopharma, Further Strengthening Its Strategic Foothold In The Us (October 25, 2022)
Who to call at Pasithea Therapeutics Corp., and when
When Pasithea Therapeutics Corp. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Pasithea Therapeutics Corp. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pasithea Therapeutics Corp., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pasithea Therapeutics Corp.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pasithea Therapeutics Corp. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Pasithea Therapeutics Corp.?
Pasithea Therapeutics Corp. was acquired by Pasithea Therapeutics Corp., based in Miami Beach. The deal was reported on October 12, 2022. Pasithea Therapeutics Corporation is a U.S. biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Pasithea Therapeutics Corp. is publicly traded (KTTA) and operates in Biotechnology.
When did Pasithea Therapeutics Corp. acquire Pasithea Therapeutics Corp.?
Pasithea Therapeutics Corp.'s acquisition of Pasithea Therapeutics Corp. was reported on October 12, 2022. Pasithea Therapeutics Corp. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Pasithea Therapeutics Corp. do?
Pasithea Therapeutics Corporation is a U.S. biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. It is publicly traded (KTTA), operating in Biotechnology, and is based in Miami Beach.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.